Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ymgme.2015.12.229
Publication URI: http://dx.doi.org/10.1016/j.ymgme.2015.12.229
Type: Journal Article/Review
Parent Publication: Molecular Genetics and Metabolism
Issue: 2